ProPhase Labs effects 1-for-10 reverse stock split to meet Nasdaq listing requirements

ProPhase Labs, Inc.

Reverse stock split at 1-for-10 ratio effective December 2, 2025, approved by board and stockholders on November 30, 2025.
Post-split common shares outstanding approximately 5,768,951; trading symbol unchanged (PRPH).
Reverse stock split implemented to increase per-share price to meet continued Nasdaq listing requirements.
Fractional shares rounded up to nearest whole share; par value remains $0.0005 per share.
Certificate of Amendment filed with Delaware Secretary of State on December 2, 2025.

item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.